Business OpportunitiesSun Pharma gains on HC order
Sun Pharma touched a high of Rs 1,459 and finally ended at Rs 1,436, up 2% from the previous close. The counter clocked volumes of 234,664 shares on the NSE today.
- HC stops Zydus drug sale on Sun petition - Sun Pharma unit gets USFDA nod for anti-allergic drug - Zydus Cadila PAT up 39% - Caraco looking at shifting production to India - Sun Pharma accuses Taro director of misusing funds - Sun Pharma net profit dips 11.5%
Cadila Healthcare erased all its losses and soared to a high of Rs 590. The scrip finally ended at Rs 589, up 3% from its previous close. The counter witnessed trades of 70,167 shares on the NSE.
_________________________________________
(Updated at 1040hrs)
Sun Pharma has gained after the Madras High Court has stopped Zydus Cadila (Cadila Healthcare) from selling anti-depressant drug, Venz (venlafaxine), in the domestic market for the time being, on the basis of the trademark complain lodged by the company.
The stock opened at Rs 1,407 and soared to a high of Rs 1,423. The stock is now trading at Rs 1,422, up 1.5% from the previous close. The counter has clocked volumes of 4,058 shares on the BSE.
Cadila Healthcare opened at Rs 560 and slipped to a low of Rs 557, down 2% from the previous close. The stock has however recoverd and is now at flat at Rs 570. The counter has clocked volumes of 1,428 shares on the BSE.